Restructuring of the extracellular matrix in diabetic wounds and healing: A perspective.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pharmacological Research

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.phrs.2016.03.008PMID 27033051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acceleration of diabetic wound healing using a novel protease–anti-protease combination therapy

  2015cited by this paper
• Matrix remodeling by MMPs during wound repair.

  2015cited by this paper
• Angiotensin II, From Vasoconstrictor to Growth Factor: A Paradigm Shift

  2014cited by this paper
• A chemical biological strategy to facilitate diabetic wound healing.

  2014cited by this paper
• Burden of Diabetic Foot Ulcers for Medicare and Private Insurers

  2014cited by this paper
• Matrix metalloproteinases in inflammation.

  2014cited by this paper
• Burden of Diabetic Foot Ulcers for Medicare and Private Insurers. Diabetes Care 2014;37:651–658

  2014cited by this paper
• Characterization of a selective inhibitor for matrix metalloproteinase-8 (MMP-8)

  2014cited by this paper
• Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.

  2013cited by this paper
• Short and long term mortality rates after a lower limb amputation.

  2013cited by this paper
• Zymography methods for visualizing hydrolytic enzymes

  2013cited by this paper
• NorLeu3‐A(1–7) stimulation of diabetic foot ulcer healing: Results of a randomized, parallel‐group, double‐blind, placebo‐controlled phase 2 clinical trial

  2012cited by this paper
• Mechanisms Involved in the Development and Healing of Diabetic Foot Ulceration

  2012cited by this paper
• A Matched Cohort Study of the Risk of Cancer in Users of Becaplermin

  2011cited by this paper
• Accelerated healing of diabetic wounds by NorLeu3-angiotensin (1-7)

  2011cited by this paper
• Selective water-soluble gelatinase inhibitor prodrugs.

  2011cited by this paper
• Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models.

  2010cited by this paper
• The role of vascular endothelial growth factor in wound healing.

  2009cited by this paper
• Active Site Ring‐Opening of a Thiirane Moiety and Picomolar Inhibition of Gelatinases

  2009cited by this paper
• Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).

  2009cited by this paper
• MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing.

  2009cited by this paper
• Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis.

  2009cited by this paper
• Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice.

  2009cited by this paper
• Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers

  2009cited by this paper
• Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells.

  2008cited by this paper
• MMPs as therapeutic targets--still a viable option?

  2008cited by this paper
• The regulation of matrix metalloproteinases and their inhibitors.

  2008cited by this paper
• Matrix metalloproteinases as modulators of inflammation.

  2008cited by this paper
• Risk Factors for Recurrent Diabetic Foot Ulcers

  2007cited by this paper
• Collagenase‐2 (MMP‐8) and matrilysin‐2 (MMP‐26) expression in human wounds of different etiologies

  2007cited by this paper
• Metabolism of a Highly Selective Gelatinase Inhibitor Generates Active Metabolite

  2007cited by this paper
• Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

  2007cited by this paper
• Growth Factors in the Treatment of Diabetic Foot Ulcers: New Technologies, Any Promises?

  2007cited by this paper
• Matrix Metalloproteinase-2 Facilitates Wound Healing Events That Promote Functional Recovery after Spinal Cord Injury

  2006cited by this paper
• Synthesis of an inhibitor-tethered resin for detection of active matrix metalloproteinases involved in disease.

  2006cited by this paper
• Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates.

  2006cited by this paper
• A Novel Function of Angiotensin II in Skin Wound Healing

  2006cited by this paper
• Lamininα3 LG4 Module Induces Keratinocyte Migration: Involvement of Matrix Metalloproteinase-9

  2005cited by this paper
• Laminin alpha3 LG4 module induces keratinocyte migration: involvement of matrix metalloproteinase-9.

  2005cited by this paper
• Matrix metalloproteinases and angiogenesis

  2005cited by this paper
• Effectiveness of recombinant human platelet‐derived growth factor for the treatment of diabetic neuropathic foot ulcers

  2005cited by this paper
• Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitors.

  2005cited by this paper
• Preventing foot ulcers in patients with diabetes.

  2005cited by this paper
• Human skin: source of and target organ for angiotensin II

  2004cited by this paper
• Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha.

  2004cited by this paper
• Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer.

  2004cited by this paper
• Matrix metalloproteinases as modulators of inflammation and innate immunity

  2004cited by this paper
• Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-α

  2004cited by this paper
• Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution

  2003cited by this paper
• Inflammation and angiotensin II.

  2003cited by this paper
• The role of matrix metalloproteinases in wound healing.

  2002cited by this paper
• Angiotensin II Angiogenic Effect In Vivo Involves Vascular Endothelial Growth Factor- and Inflammation-Related Pathways

  2002cited by this paper
• Nonremodeling properties of matrix metalloproteinases: the platelet connection.

  2002cited by this paper
• Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients

  2002cited by this paper
• Matrix Metalloproteinase Gelatinase B (MMP-9) Coordinates and Effects Epithelial Regeneration*

  2002cited by this paper
• Discoidin Domain Receptor 2 Regulates Fibroblast Proliferation and Migration through the Extracellular Matrix in Association with Transcriptional Activation of Matrix Metalloproteinase-2*

  2002cited by this paper
• Matrix metalloproteinases: they're not just for matrix anymore!

  2001cited by this paper
• Angiotensin II Induces Migration and Pyk2/Paxillin Phosphorylation of Human Monocytes

  2001cited by this paper
• Recombinant human platelet‐derived growth factor‐BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open‐label clinical evaluation of efficacy

  2000cited by this paper
• Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.

  2000cited by this paper
• Matrix metalloproteinases and angiogenesis

  2000cited by this paper
• Binding of Active (57 kDa) Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) to Tissue Inhibitor of Metalloproteinase (TIMP)-2 Regulates MT1-MMP Processing and Pro-MMP-2 Activation*

  2000cited by this paper
• Fibroblast growth factor-2.

  2000cited by this paper
• Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity.

  2000cited by this paper
• Potent and Selective Mechanism-Based Inhibition of Gelatinases

  2000cited by this paper
• Role of Cell Surface Metalloprotease Mt1-Mmp in Epithelial Cell Migration over Laminin-5

  2000cited by this paper
• Form and function: The laminin family of heterotrimers

  2000cited by this paper
• Mechanism of action and in vivo role of platelet-derived growth factor.

  1999cited by this paper
• Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.

  1999cited by this paper
• Epidermal growth factor (EGF)‐ and scatter factor/hepatocyte growth factor (SF/HGF)‐mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)‐9

  1998cited by this paper
• Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind study

  1998cited by this paper
• Kinetic Analysis of the Binding of Human Matrix Metalloproteinase-2 and -9 to Tissue Inhibitor of Metalloproteinase (TIMP)-1 and TIMP-2*

  1997cited by this paper
• The Activity of Collagenase-1 Is Required for Keratinocyte Migration on a Type I Collagen Matrix

  1997cited by this paper
• Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5.

  1997cited by this paper
• Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).

  1995cited by this paper
• Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group.

  1995cited by this paper
• Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens

  1993cited by this paper
• Platelet-derived growth factor is angiogenic in vivo.

  1992cited by this paper
• Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.

  1992cited by this paper
• Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor.

  1985cited by this paper
• The FASEB Journal • Research Communication Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8)

  year unknowncited by this paper

• A bibliometric and visual analysis of colorectal cancer-diabetes comorbidity

  2026cites this paper
• TAK1 activates PANoptosis through the NF-κB signalling pathway to delay diabetic wound healing

  2026cites this paper
• The protective effects of Silymarin in diabetic wound healing: A review.

  2026cites this paper
• Microenvironment Modulation‐Based Nanomaterial‐Loaded Hydrogel Dressings for Diabetic Foot Ulcers: Research Progress and Future Perspectives

  2026cites this paper
• Bridging traditional Chinese medicine theory with advanced MOFs delivery for synergistic drug-resistant infected-chronic wound therapy

  2026cites this paper
• Fish and bovine collagen promote higher migration and adhesion of dermal cells pre-treated with wound-healing herbal extracts.

  2025cites this paper
• Research Progress of Natural Polysaccharide-Based Hydrogels in Skin Tissue Regeneration

  2025cites this paper
• Indonesian honey as a natural remedy: Accelerating wound healing in Staphylococcus-infected mice

  2025cites this paper
• O-linked β-N-acetylglucosamine modification in diabetic foot ulcer pathogenesis

  2025cites this paper
• Desalinated Lava Seawater Promotes Wound Healing by MMP9 Through Activating ERK Pathways in HaCaT Cells

  2025cites this paper
• A Smart Functional Microneedle, Tethered with Neuropeptide S and Tissue Inhibitor of Metalloproteinases, Promotes Skin, Vascular, and Nerve Regeneration for Chronic Diabetic Skin Wound Healing

  2025cites this paper
• Phytochemical nanozymes reprogram redox for balanced antimicrobial and regenerative therapy in acute and chronic diabetic wounds

  2025influential citation
• An enzyme-responsive hydrogel of ferrocene-grafted carboxymethyl chitosan as a soft electrochemical sensor for MMP-9 detection.

  2024cites this paper
• Hyaluronic Acid‐Based Self‐Healing Hydrogels for Diabetic Wound Healing

  2024cites this paper
• Enhancing diabetic foot ulcer healing: Impact of the regulation of the FUS and ILF2 RNA-binding proteins through negative pressure wound therapy

  2024cites this paper
• Evaluation of Diabetic Wound Healing Activity of Novel Quercetin Topical Preparations

  2024cites this paper
• Nanoengineered Tools in the Treatment of Diabetic Wounds: a Review on Next-Generation Multidimensional Therapeutic Approaches

  2024cites this paper
• Design Strategy of Microneedle Systems for Skin Wound Healing: Based on the Structure of Tips and Therapeutic Methodologies.

  2024cites this paper
• Gelatin Microspheres Based on H8-Loaded Macrophage Membrane Vesicles to Promote Wound Healing in Diabetic Mice.

  2024cites this paper
• Targeting matrix metalloproteases in diabetic wound healing

  2023cites this paper
• Topical siRNA therapy of diabetic-like wound healing

  2023cites this paper
• Network pharmacology reveals the potential of Dolastatin 16 as a diabetic wound healing agent

  2023cites this paper
• Utilization of ActiGraft an Autologous Whole Blood Clot for Treatment of Complex Wounds Linked to Comorbidities

  2023cites this paper
• High glucose-induced STING activation inhibits diabetic wound healing through promoting M1 polarization of macrophages

  2023cites this paper
• Antioxidant and anti-inflammatory properties of pine pollen extract promote wound healing

  2023cites this paper
• Role of matrix metalloproteinase in wound healing.

  2022cites this paper
• Proteolytic signaling in cutaneous wound healing

  2022cites this paper
• IL-25 improves diabetic wound healing through stimulating M2 macrophage polarization and fibroblast activation.

  2022cites this paper
• A pH-responsive hyaluronic acid hydrogel for regulating the inflammation and remodeling of the ECM in diabetic wounds.

  2022cites this paper
• Innovative treatment utilizing an autologous blood clot for diabetic foot ulcers.

  2022cites this paper
• Honey: An Advanced Antimicrobial and Wound Healing Biomaterial for Tissue Engineering Applications

  2022cites this paper
• Mesenchymal stem cell-derived exosomes: The dawn of diabetic wound healing

  2022cites this paper
• High Glucose Activates ERK1/2 to Stabilize AP1 and Increase MMP9 Expression in Diabetic Foot Ulcers.

  2021cites this paper
• Biomimetic Hydrogels to Promote Wound Healing

  2021cites this paper
• A novel nonlocal partial differential equation model of endothelial progenitor cell cluster formation during the early stages of vasculogenesis.

  2021cites this paper
• A mathematical model of endothelial progenitor cell cluster formation during the early stages of vasculogenesis

  2021cites this paper
• Metabolism of the Selective Matrix Metalloproteinase-9 Inhibitor (R)-ND-336.

  2021cites this paper
• Transplantation of human amniotic epithelial cells promotes morphological and functional regeneration in a rat uterine scar model

  2021cites this paper
• Effects of Rutin on Wound Healing in Hyperglycemic Rats

  2020influential citation
• The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases

  2020cites this paper
• Cellular Senescence as the Pathogenic Hub of Diabetes-Related Wound Chronicity

  2020cites this paper
• Targeting MMP-9 in Diabetic Foot Ulcers

  2019cites this paper
• Neuroscientific Research for Management of Dementia

  2019cites this paper
• Elevated Thrombospondin 2 Contributes to Delayed Wound Healing in Diabetes

  2019cites this paper
• Mesenchymal Stem Cells Coated by the Extracellular Matrix Promote Wound Healing in Diabetic Rats

  2019cites this paper
• Expression of active matrix metalloproteinase‐9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers

  2018cites this paper
• The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment

  2017cites this paper
• Metaloproteinasas de la matriz extracelular y su participación en el proceso de cicatrización

  2017cites this paper
• Biological Activity and Implications of the Metalloproteinases in Diabetic Foot Ulcers

  2017cites this paper
• [Research progress on the animal models and treatment strategies of diabetic foot ulcer].

  2017cites this paper
• Topical 1% propranolol cream promotes cutaneous wound healing in spontaneously diabetic mice

  2017cites this paper
• Enhanced migration of murine fibroblast-like 3T3-L1 preadipocytes on type I collagen-coated dish is reversed by silibinin treatment

  2017cites this paper
• Roles of Matrix Metalloproteinases in Cutaneous Wound Healing

  2016cites this paper
• Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in Diagnosis

  2016cites this paper
• World Journal of Diabetes

  year unknowncites this paper